References
Wiestner A, Schlemper RJ, van der Maas AP, Skoda RC (1998) An activating splice donor mutation in the thrombopoietin gene causes hereditary thrombocythaemia. Nat Genet 18(1):49–52. https://doi.org/10.1038/ng0198-49
Ding J, Komatsu H, Wakita A, Kato-Uranishi M, Ito M, Satoh A, Tsuboi K, Nitta M, Miyazaki H, Iida S, Ueda R (2004) Familial essential thrombocythemia associated with a dominant-positive activating mutation of the c-MPL gene, which encodes for the receptor for thrombopoietin. Blood 103(11):4198–4200. https://doi.org/10.1182/blood-2003-10-3471
Etheridge SL, Cosgrove ME, Sangkhae V, Corbo LM, Roh ME, Seeliger MA, Chan EL, Hitchcock IS (2014) A novel activating, germline JAK2 mutation, JAK2R564Q, causes familial essential thrombocytosis. Blood 123(7):1059–1068. https://doi.org/10.1182/blood-2012-12-473777
Rumi E, Harutyunyan AS, Casetti I, Pietra D, Nivarthi H, Moriggl R, Cleary C, Bagienski K, Astori C, Bellini M, Berg T, Passamonti F, Kralovics R, Cazzola M (2014) A novel germline JAK2 mutation in familial myeloproliferative neoplasms. Am J Hematol 89(1):117–118. https://doi.org/10.1002/ajh.23614
Mead AJ, Rugless MJ, Jacobsen SE, Schuh A (2012) Germline JAK2 mutation in a family with hereditary thrombocytosis. N Engl J Med 366(10):967–969. https://doi.org/10.1056/NEJMc1200349
Marty C, Saint-Martin C, Pecquet C, Grosjean S, Saliba J, Mouton C, Leroy E, Harutyunyan AS, Abgrall JF, Favier R, Toussaint A, Solary E, Kralovics R, Constantinescu SN, Najman A, Vainchenker W, Plo I, Bellanne-Chantelot C (2014) Germ-line JAK2 mutations in the kinase domain are responsible for hereditary thrombocytosis and are resistant to JAK2 and HSP90 inhibitors. Blood 123(9):1372–1383. https://doi.org/10.1182/blood-2013-05-504555
Yoshizato T, Nannya Y, Atsuta Y, Shiozawa Y, Iijima-Yamashita Y, Yoshida K, Shiraishi Y, Suzuki H, Nagata Y, Sato Y, Kakiuchi N, Matsuo K, Onizuka M, Kataoka K, Chiba K, Tanaka H, Ueno H, Nakagawa MM, Przychodzen B, Haferlach C, Kern W, Aoki K, Itonaga H, Kanda Y, Sekeres MA, Maciejewski JP, Haferlach T, Miyazaki Y, Horibe K, Sanada M, Miyano S, Makishima H, Ogawa S (2017) Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantation. Blood 129(17):2347–2358. https://doi.org/10.1182/blood-2016-12-754796
Acknowledgements
We thank Thomas Mayers, assistant professor of English for Medical Purposes, Medical English Communications Center, University of Tsukuba, for his editorial assistance.
Author information
Authors and Affiliations
Contributions
KM and YY wrote the manuscript. KM performed the experiments using patient samples. YN and SO performed panel sequencing for 67 genes. YY and MN performed histopathological analysis. YY, TK, MSY, and SC supervised this research. All authors approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Informed consent
This study was approved by ethics committee in University of Tsukuba Hospital, and informed consent was obtained from the patient and her family members before the analysis.
Rights and permissions
About this article
Cite this article
Maie, K., Yokoyama, Y., Yano, Y. et al. Progression to polythythemia vera from familial thrombocytosis with germline JAK2 R867Q mutation. Ann Hematol 97, 737–739 (2018). https://doi.org/10.1007/s00277-017-3209-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-017-3209-1